Sutro Biopharma Stock Price on December 10, 2024
| STRO Stock | USD 1.93 0.06 3.21% |
Below is the normalized historical share price chart for Sutro Biopharma extending back to September 27, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Sutro Biopharma stands at 1.93, as last reported on the 24th of December, with the highest price reaching 1.93 and the lowest price hitting 1.83 during the day.
If you're considering investing in Sutro Stock, it is important to understand the factors that can impact its price. Sutro Biopharma owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.13, which indicates the firm had a -0.13% return per unit of risk over the last 3 months. Sutro Biopharma exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Sutro Biopharma's Coefficient Of Variation of (565.37), variance of 26.99, and Risk Adjusted Performance of (0.13) to confirm the risk estimate we provide.
As of the 24th of December 2024, Total Stockholder Equity is likely to drop to about 134.9 M. In addition to that, Common Stock Shares Outstanding is likely to drop to about 31.9 M. As of the 24th of December 2024, Price To Sales Ratio is likely to drop to 1.59. In addition to that, Price Earnings Ratio is likely to grow to -2.3. Sutro Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 27th of September 2018 | 200 Day MA 3.7303 | 50 Day MA 3.1208 | Beta 1.168 |
Sutro |
Sharpe Ratio = -0.1341
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | STRO |
Estimated Market Risk
| 5.24 actual daily | 46 54% of assets are more volatile |
Expected Return
| -0.7 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.13 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Sutro Biopharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Sutro Biopharma by adding Sutro Biopharma to a well-diversified portfolio.
Price Book 1.3938 | Enterprise Value Ebitda 0.4055 | Price Sales 0.958 | Shares Float 69.3 M | Wall Street Target Price 11.5 |
Related Headline
Merus BV Headline on 10th of December 2024
Wellington Management Group LLP Purchases 1,224,573 Shares o... by thelincolnianonline.com
Wellington Management Group LLP grew its position in shares of Merus by 73.6 percent during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,887,514 shares of the biotechnology companys stock after purchasing an additional 1,224,573 shares during the quarter. Wellington Management
Sutro Biopharma Valuation on December 10, 2024
It is possible to determine the worth of Sutro Biopharma on a given historical date. On December 10, 2024 Sutro was worth 2.79 at the beginning of the trading date compared to the closed value of 2.35. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Sutro Biopharma stock. Still, in general, we apply an absolute valuation method to find Sutro Biopharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Sutro Biopharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Sutro Biopharma's related companies.
| Open | High | Low | Close | Volume | |
| 2.91 | 3.01 | 2.81 | 2.81 | 1,090,752 | |
12/10/2024 | 2.79 | 2.84 | 2.32 | 2.35 | 3,618,453 |
| 2.38 | 2.48 | 2.31 | 2.45 | 1,239,936 |
| Backtest Sutro Biopharma | | | Sutro Biopharma History | | | Sutro Biopharma Valuation | Previous | Next |
Sutro Biopharma Trading Date Momentum on December 10, 2024
| On December 11 2024 Sutro Biopharma was traded for 2.45 at the closing time. The top price for the day was 2.48 and the lowest listed price was 2.31 . The trading volume for the day was 1.2 M. The trading history from December 11, 2024 was a factor to the next trading day price boost. The trading price change against the next closing price was 4.26% . The trading price change against the current closing price is 23.83% . |
Sutro Biopharma Fundamentals Correlations and Trends
By evaluating Sutro Biopharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Sutro Biopharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Sutro financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Sutro Biopharma Stock history
Sutro Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Sutro is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Sutro Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Sutro Biopharma stock prices may prove useful in developing a viable investing in Sutro Biopharma
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 60.2 M | 31.9 M | |
| Net Loss | -107.3 M | -101.9 M |
Sutro Biopharma Quarterly Net Working Capital |
|
Sutro Biopharma Stock Technical Analysis
Sutro Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Sutro Biopharma Period Price Range
Low | December 24, 2024
| High |
0.00 | 0.00 |
Sutro Biopharma cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Sutro Biopharma December 24, 2024 Market Strength
Market strength indicators help investors to evaluate how Sutro Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Sutro Biopharma shares will generate the highest return on investment. By undertsting and applying Sutro Biopharma stock market strength indicators, traders can identify Sutro Biopharma entry and exit signals to maximize returns
Sutro Biopharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Sutro Biopharma's price direction in advance. Along with the technical and fundamental analysis of Sutro Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Sutro to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.13) | |||
| Jensen Alpha | (1.01) | |||
| Total Risk Alpha | (1.08) | |||
| Treynor Ratio | (0.27) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sutro Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Sutro Stock, please use our How to Invest in Sutro Biopharma guide.You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sutro Biopharma. If investors know Sutro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sutro Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.55) | Revenue Per Share 2.253 | Quarterly Revenue Growth (0.50) | Return On Assets (0.18) | Return On Equity (1.11) |
The market value of Sutro Biopharma is measured differently than its book value, which is the value of Sutro that is recorded on the company's balance sheet. Investors also form their own opinion of Sutro Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Sutro Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sutro Biopharma's market value can be influenced by many factors that don't directly affect Sutro Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sutro Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sutro Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sutro Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.